Peer Mentoring Program for Informal Caregivers of Homebound Individuals With Advanced Parkinson Disease (Share the Care): Protocol for a Single-Center, Crossover Pilot Study.

Parkinson disease anxiety care partner caregiver strain caregiving carer depression intervention peer mentor peer support volunteer

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
26 May 2022
Historique:
received: 06 11 2021
accepted: 28 04 2022
revised: 27 04 2022
pubmed: 29 4 2022
medline: 29 4 2022
entrez: 28 4 2022
Statut: epublish

Résumé

Homebound individuals with advanced Parkinson disease (PD) require intensive caregiving, the majority of which is provided by informal, family caregivers. PD caregiver strain is an independent risk factor for institutionalization. There are currently no effective interventions to support advanced PD caregivers. Studies in other neurologic disorders, however, have demonstrated the potential for peer mentoring interventions to improve caregiver outcomes. In the context of an ongoing trial of interdisciplinary home visits, we designed and piloted a nested trial of caregiver peer mentoring for informal caregivers of individuals with advanced PD. The aim of this study was to test the feasibility of peer mentoring for caregivers of homebound individuals with advanced PD and to evaluate its effects on anxiety, depression, and caregiver strain. This was a single-center, 16-week pilot study of caregiver peer mentoring nested within a year-long controlled trial of interdisciplinary home visits. We recruited 34 experienced former or current family caregivers who completed structured mentor training. Caregivers enrolled in the larger interdisciplinary home visit trial consented to receive 16 weeks of weekly, one-to-one peer mentoring calls with a trained peer mentor. Weekly calls were guided by a curriculum on advanced PD management and caregiver support. Fidelity to and satisfaction with the intervention were gathered via biweekly study diaries. Anxiety, depression, and caregiver strain were measured pre- and postmentoring intervention at home visits 2 and 3. Enrollment and peer-mentor training began in 2018, and 65 caregivers enrolled in the overarching trial. The majority of mentors and mentees were White, female spouses or partners of individuals with PD; mentors had a mean of 8.7 (SD 6.4) years of caregiving experience, and 33 mentors were matched with at least 1 mentee. This is the first study of caregiver peer mentoring in PD and may establish an adaptable and sustainable model for disease-specific caregiver interventions in PD and other neurodegenerative diseases. ClinicalTrials.gov NCT03189459; http://clinicaltrials.gov/ct2/show/NCT03189459. DERR1-10.2196/34750.

Sections du résumé

BACKGROUND BACKGROUND
Homebound individuals with advanced Parkinson disease (PD) require intensive caregiving, the majority of which is provided by informal, family caregivers. PD caregiver strain is an independent risk factor for institutionalization. There are currently no effective interventions to support advanced PD caregivers. Studies in other neurologic disorders, however, have demonstrated the potential for peer mentoring interventions to improve caregiver outcomes. In the context of an ongoing trial of interdisciplinary home visits, we designed and piloted a nested trial of caregiver peer mentoring for informal caregivers of individuals with advanced PD.
OBJECTIVE OBJECTIVE
The aim of this study was to test the feasibility of peer mentoring for caregivers of homebound individuals with advanced PD and to evaluate its effects on anxiety, depression, and caregiver strain.
METHODS METHODS
This was a single-center, 16-week pilot study of caregiver peer mentoring nested within a year-long controlled trial of interdisciplinary home visits. We recruited 34 experienced former or current family caregivers who completed structured mentor training. Caregivers enrolled in the larger interdisciplinary home visit trial consented to receive 16 weeks of weekly, one-to-one peer mentoring calls with a trained peer mentor. Weekly calls were guided by a curriculum on advanced PD management and caregiver support. Fidelity to and satisfaction with the intervention were gathered via biweekly study diaries. Anxiety, depression, and caregiver strain were measured pre- and postmentoring intervention at home visits 2 and 3.
RESULTS RESULTS
Enrollment and peer-mentor training began in 2018, and 65 caregivers enrolled in the overarching trial. The majority of mentors and mentees were White, female spouses or partners of individuals with PD; mentors had a mean of 8.7 (SD 6.4) years of caregiving experience, and 33 mentors were matched with at least 1 mentee.
CONCLUSIONS CONCLUSIONS
This is the first study of caregiver peer mentoring in PD and may establish an adaptable and sustainable model for disease-specific caregiver interventions in PD and other neurodegenerative diseases.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT03189459; http://clinicaltrials.gov/ct2/show/NCT03189459.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/34750.

Identifiants

pubmed: 35481819
pii: v11i5e34750
doi: 10.2196/34750
pmc: PMC9185354
doi:

Banques de données

ClinicalTrials.gov
['NCT03189459']

Types de publication

Journal Article

Langues

eng

Pagination

e34750

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS097615
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066512
Pays : United States

Informations de copyright

©Jori E Fleisher, Faizan Akram, Jeanette Lee, Ellen C Klostermann, Serena P Hess, Erica Myrick, Melissa Levin, Bichun Ouyang, Jayne Wilkinson, Deborah A Hall, Joshua Chodosh. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 26.05.2022.

Références

Int J Nurs Stud. 2012 Apr;49(4):445-54
pubmed: 22036578
Parkinsonism Relat Disord. 2015 Jun;21(6):629-34
pubmed: 25892660
Am J Alzheimers Dis Other Demen. 2003 Mar-Apr;18(2):115-22
pubmed: 12708227
J Am Geriatr Soc. 2008 Mar;56(3):421-8
pubmed: 18179495
J Aging Health. 2019 Feb;31(2):256-279
pubmed: 29254402
Health Soc Care Community. 2017 Mar;25(2):548-558
pubmed: 26970311
Neurol Clin Pract. 2020 Aug;10(4):277-286
pubmed: 32983607
Mov Disord. 2009 Aug 15;24(11):1641-9
pubmed: 19514014
Geriatr Nurs. 2015 May-Jun;36(3):207-11
pubmed: 25744558
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Mov Disord. 2005 Feb;20(2):190-9
pubmed: 15551331
Am J Alzheimers Dis Other Demen. 2017 Mar;32(2):90-95
pubmed: 28116927
Mov Disord. 2019 Feb;34(2):236-245
pubmed: 30589953
Fam Pract. 2010 Jun;27 Suppl 1:i17-22
pubmed: 19509083
Prim Health Care Res Dev. 2015 Apr;16(2):201-6
pubmed: 24451938
Parkinsonism Relat Disord. 2013 Nov;19(11):949-54
pubmed: 23835430
J Geriatr Psychiatry Neurol. 2018 Nov;31(6):319-328
pubmed: 30244631
Am J Alzheimers Dis Other Demen. 2013 Sep;28(6):617-26
pubmed: 23813790
JMIR Res Protoc. 2021 Sep 14;10(9):e31690
pubmed: 34238753
J Am Geriatr Soc. 2015 Feb;63(2):282-9
pubmed: 25688604
Int J Nurs Stud. 2014 Mar;51(3):359-69
pubmed: 23850390
Qual Life Res. 2009 Aug;18(6):679-88
pubmed: 19421895
J Parkinsons Dis. 2020;10(3):1087-1098
pubmed: 32444563
Palliat Med. 2017 Jul;31(7):634-641
pubmed: 27683476
Nephrol News Issues. 2003 Jul;17(8):28-31
pubmed: 12882109
J Parkinsons Dis. 2020;10(s1):S75-S83
pubmed: 32568114
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
BMJ. 2008 Jun 7;336(7656):1295-7
pubmed: 18505757
Mov Disord Clin Pract. 2021 Apr 12;8(4):510-520
pubmed: 33981783
Neurology. 2007 Jan 30;68(5):384-6
pubmed: 17082464
Parkinsonism Relat Disord. 2013 Nov;19(11):975-9
pubmed: 23871587
Am J Alzheimers Dis Other Demen. 2014 Feb;29(1):8-17
pubmed: 24085253
Front Neurol. 2021 Aug 05;12:673893
pubmed: 34434156
Semin Dial. 2018 Sep;31(5):455-461
pubmed: 29722062
BMJ. 2015 Feb 06;350:h391
pubmed: 25662947
J Appl Gerontol. 2021 Aug;40(8):881-889
pubmed: 32401118
J Am Geriatr Soc. 2018 Jul;66(6):1226-1232
pubmed: 29608779
Parkinsonism Relat Disord. 2006 Jan;12(1):35-41
pubmed: 16271496
Front Neurol. 2021 Feb 01;12:633645
pubmed: 33597918
Aging Ment Health. 2002 May;6(2):153-60
pubmed: 12028884
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Parkinsonism Relat Disord. 2019 Jul;64:106-111
pubmed: 30930058
J Parkinsons Dis. 2018;8(s1):S3-S8
pubmed: 30584159
J Geriatr Psychiatry Neurol. 2020 Jan;33(1):3-14
pubmed: 31146617
PLoS One. 2017 Jul 6;12(7):e0180425
pubmed: 28683150
J Cancer Educ. 2021 Aug;36(4):710-718
pubmed: 31994006
Clin Interv Aging. 2019 Jul 31;14:1371-1377
pubmed: 31534322
J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1218-1228
pubmed: 27521377

Auteurs

Jori E Fleisher (JE)

Rush University Medical Center, Chicago, IL, United States.

Faizan Akram (F)

Rush University Medical Center, Chicago, IL, United States.

Jeanette Lee (J)

Rush University Medical Center, Chicago, IL, United States.

Ellen C Klostermann (EC)

Rush University Medical Center, Chicago, IL, United States.

Serena P Hess (SP)

Rush University Medical Center, Chicago, IL, United States.

Erica Myrick (E)

Rush University Medical Center, Chicago, IL, United States.
Western Michigan University Homer Stryker M D School of Medicine, Kalamazoo, MI, United States.

Melissa Levin (M)

Rush University Medical Center, Chicago, IL, United States.
Chicago Medical School, Rosalind Franklin University, North Chicago, IL, United States.

Bichun Ouyang (B)

Rush University Medical Center, Chicago, IL, United States.

Jayne Wilkinson (J)

Rush University Medical Center, Chicago, IL, United States.
Department of Neurology, University of Pennsylvania, Pennsylvania, PA, United States.

Deborah A Hall (DA)

Rush University Medical Center, Chicago, IL, United States.

Joshua Chodosh (J)

Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York University School of Medicine, New York, NY, United States.
Medicine Service, Veterans Affairs New York Harbor Healthcare System, New York, NY, United States.

Classifications MeSH